Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Share-based Compensation (2016 - 2021)

Phio Pharmaceuticals' Share-based Compensation history spans 10 years, with the latest figure at $138000.0 for Q4 2021.

  • For Q4 2021, Share-based Compensation rose 430.77% year-over-year to $138000.0; the TTM value through Dec 2021 reached $480000.0, up 252.94%, while the annual FY2025 figure was $481000.0, 227.21% up from the prior year.
  • Share-based Compensation reached $138000.0 in Q4 2021 per PHIO's latest filing, down from $143000.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $165000.0 in Q4 2018 to a low of $26000.0 in Q4 2020.
  • Average Share-based Compensation over 5 years is $75600.0, with a median of $45000.0 recorded in 2017.
  • Peak YoY movement for Share-based Compensation: plummeted 81.21% in 2019, then skyrocketed 430.77% in 2021.
  • A 5-year view of Share-based Compensation shows it stood at $38000.0 in 2017, then surged by 334.21% to $165000.0 in 2018, then tumbled by 81.21% to $31000.0 in 2019, then fell by 16.13% to $26000.0 in 2020, then surged by 430.77% to $138000.0 in 2021.
  • Per Business Quant, the three most recent readings for PHIO's Share-based Compensation are $138000.0 (Q4 2021), $143000.0 (Q3 2021), and $132000.0 (Q2 2021).